The patents contain ADHD-use claims for the entire family of P2D’s first-in-class dopamine transport inhibitors, including PD2005 and PD2007. Initial studies indicate that P2D’s lead compounds are as
Provectus Pharmaceuticals has already concluded patient recruitment and treatment of all subjects in its PV-10 Phase 1 clinical trial for liver cancer in January 2011. Preliminary analysis of
The goal of the collaboration is to develop a therapeutic approach for Parkinson’s disease that combines the strengths of Lilly’s biologic, a modified form of glial cell derived
In the submission, Columbia Laboratories has requested Priority Review to the FDA. The NDA submission includes data from two Phase III clinical trials evaluating the use of Prochieve
Currently, Velcade is approved for intravenous use only for the patients who are suffering from multiple myeloma and for patients with mantle cell lymphoma who have received at
The acquisition of Lexi-Comp will enable Wolters Kluwer Health to further strengthen its position in the clinical decision support and point-of-care information segments and to provide customers with
PharmStar Pharma is a developer, manufacturer and marketer of Aquaprin, an FDA-approved over-the-counter (OTC) liquid derivative of aspirin based on a patent-pending formula. The company has put together
The Phase IIb trial will compare the safety and efficacy of two dose levels of TB-402, given as a single intravenous infusion after hip surgery, with the recently
Durata has taken over the Japanese commercialization rights for dalbavancin from RaQualia Pharma in December 2010. All other rights, including in North America and the European Union, were
The milestone marks the completion of the Lerentang Pharmaceutical company’s manufacturing facility relocation from Shijiazhuang to Xinle City and Hebei Province. Aoxing Pharma has obtained $269,231 in the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.